New study suggests 21-gene recurrence score may help in radiation decision-making
A new study shows that a test physicians commonly used to guide chemotherapy treatment for post-breast cancer surgery patients may also help them decide whether radiation therapy may be of benefit. Known as the 21-gene recurrence score, the test is a personalized analysis of the activity of 21 genes found in a patient’s breast tumor…